Camp4 Therapeutics Corporation (CAMP)
NASDAQ: CAMP · Real-Time Price · USD
3.800
-0.290 (-7.09%)
Nov 13, 2026, 4:00 PM EST - Market closed

Camp4 Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
Cash & Equivalents
124.52109.5264.0438.3883.19
Cash & Short-Term Investments
124.52109.5264.0438.3883.19
Cash Growth
65.47%71.02%66.86%-53.86%-
Accounts Receivable
-0.16---
Other Receivables
0.22-0.110.440.68
Receivables
0.220.160.110.440.68
Prepaid Expenses
0.030.560.590.360.16
Restricted Cash
0.731.35---
Other Current Assets
2.042.521.650.830.38
Total Current Assets
127.54114.166.3840.0184.41
Property, Plant & Equipment
5.522.749.8713.3116.79
Other Long-Term Assets
0.960.982.051.621.35
Total Assets
134.01117.8178.3154.95102.55

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
Accounts Payable
0.760.181.211.042.15
Accrued Expenses
6.815.544.33.013.17
Current Portion of Long-Term Debt
-0.030.180.41-
Current Portion of Leases
1.630.292.993.062.37
Current Unearned Revenue
10.59.390.39--
Other Current Liabilities
0.170.090.540.290.26
Total Current Liabilities
19.8715.519.67.817.95
Long-Term Debt
---0.09-
Long-Term Leases
4.831.695.498.6410.03
Long-Term Unearned Revenue
2.188.11---
Other Long-Term Liabilities
0.0544.790.070-0.04
Total Liabilities
26.9270.115.1616.5317.93

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
Common Stock
0.010.01000
Additional Paid-In Capital
480.06339.85274.936.2333.14
Retained Earnings
-372.97-292.16-211.75-159.96-110.67
Total Common Equity
107.0947.763.14-123.73-77.53
Shareholders' Equity
107.0947.763.1438.4284.62
Total Liabilities & Equity
134.01117.8178.3154.95102.55

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
Total Debt
6.4528.6612.1812.4
Net Cash (Debt)
118.07107.5255.3826.270.8
Net Cash Growth
71.34%94.16%111.38%-63.00%-
Net Cash Per Share
1.903.5411.8166.33226.69
Filing Date Shares Outstanding
62.7551.9220.150.460.31
Total Common Shares Outstanding
62.7551.920.150.460.31
Working Capital
107.6798.5856.7932.2176.46
Book Value Per Share
1.710.923.13-268.57-248.26
Tangible Book Value
107.0947.763.14-123.73-77.53
Tangible Book Value Per Share
1.710.923.13-268.57-248.26
Machinery
4.735.575.574.784.17
Leasehold Improvements
0.024.524.524.524.52
SEC Filings: 10-K · 10-Q